876 related articles for article (PubMed ID: 26318557)
1. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
[TBL] [Abstract][Full Text] [Related]
3. Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation.
Mehra R; Rani C; Mahajan P; Vishwakarma RA; Khan IA; Nargotra A
ACS Comb Sci; 2016 Feb; 18(2):100-16. PubMed ID: 26812086
[TBL] [Abstract][Full Text] [Related]
4. Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU).
Tran AT; Wen D; West NP; Baker EN; Britton WJ; Payne RJ
Org Biomol Chem; 2013 Dec; 11(46):8113-26. PubMed ID: 24158720
[TBL] [Abstract][Full Text] [Related]
5. Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase.
Zhang W; Jones VC; Scherman MS; Mahapatra S; Crick D; Bhamidi S; Xin Y; McNeil MR; Ma Y
Int J Biochem Cell Biol; 2008; 40(11):2560-71. PubMed ID: 18573680
[TBL] [Abstract][Full Text] [Related]
6. The Inhibitory Effect of GlmU Acetyltransferase Inhibitor TPSA on
Chen C; Han X; Yan Q; Wang C; Jia L; Taj A; Zhao L; Ma Y
Front Cell Infect Microbiol; 2019; 9():251. PubMed ID: 31380295
[No Abstract] [Full Text] [Related]
7. Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU.
Li Y; Zhou Y; Ma Y; Li X
Carbohydr Res; 2011 Sep; 346(13):1714-20. PubMed ID: 21704310
[TBL] [Abstract][Full Text] [Related]
8. PknB-mediated phosphorylation of a novel substrate, N-acetylglucosamine-1-phosphate uridyltransferase, modulates its acetyltransferase activity.
Parikh A; Verma SK; Khan S; Prakash B; Nandicoori VK
J Mol Biol; 2009 Feb; 386(2):451-64. PubMed ID: 19121323
[TBL] [Abstract][Full Text] [Related]
9. Kinetic properties of Mycobacterium tuberculosis bifunctional GlmU.
Zhou Y; Xin Y; Sha S; Ma Y
Arch Microbiol; 2011 Oct; 193(10):751-7. PubMed ID: 21594607
[TBL] [Abstract][Full Text] [Related]
10. Escherichia coli N-Acetylglucosamine-1-Phosphate-Uridyltransferase/Glucosamine-1-Phosphate-Acetyltransferase (GlmU) Inhibitory Activity of Terreic Acid Isolated from Aspergillus terreus.
Sharma R; Lambu MR; Jamwal U; Rani C; Chib R; Wazir P; Mukherjee D; Chaubey A; Khan IA
J Biomol Screen; 2016 Apr; 21(4):342-53. PubMed ID: 26762501
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity.
Soni V; Suryadevara P; Sriram D; ; Kumar S; Nandicoori VK; Yogeeswari P
J Mol Model; 2015 Jul; 21(7):174. PubMed ID: 26078037
[TBL] [Abstract][Full Text] [Related]
12. UDP-GlcNAc pathway: Potential target for inhibitor discovery against M. tuberculosis.
Rani C; Khan IA
Eur J Pharm Sci; 2016 Feb; 83():62-70. PubMed ID: 26690048
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
14. Identification of amino acids involved in catalytic process of M. tuberculosis GlmU acetyltransferase.
Zhou Y; Yu W; Zheng Q; Xin Y; Ma Y
Glycoconj J; 2012 Aug; 29(5-6):297-303. PubMed ID: 22669463
[TBL] [Abstract][Full Text] [Related]
15. The Mechanism of Acetyl Transfer Catalyzed by Mycobacterium tuberculosis GlmU.
Craggs PD; Mouilleron S; Rejzek M; de Chiara C; Young RJ; Field RA; Argyrou A; de Carvalho LPS
Biochemistry; 2018 Jun; 57(24):3387-3401. PubMed ID: 29684272
[TBL] [Abstract][Full Text] [Related]
16. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
17. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
[TBL] [Abstract][Full Text] [Related]
18. Identification and optimization of Escherichia coli GlmU inhibitors: an in silico approach with validation thereof.
Mehra R; Sharma R; Khan IA; Nargotra A
Eur J Med Chem; 2015 Mar; 92():78-90. PubMed ID: 25544688
[TBL] [Abstract][Full Text] [Related]
19. Unique C-terminal extension and interactome of Mycobacterium tuberculosis GlmU impacts it's in vivo function and the survival of pathogen.
Agarwal M; Soni V; Kumar S; Singha B; Nandicoori VK
Biochem J; 2021 Jun; 478(11):2081-2099. PubMed ID: 33955473
[TBL] [Abstract][Full Text] [Related]
20. Action of Dicumarol on Glucosamine-1-Phosphate Acetyltransferase of GlmU and
Han X; Chen C; Yan Q; Jia L; Taj A; Ma Y
Front Microbiol; 2019; 10():1799. PubMed ID: 31481936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
